Ajanta Pharma Limited
NSE: AJANTPHARM.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Yogesh Mannalal Agrawal
- Employees
- 8,073
- Headquarters
- Mumbai, India
- IPO year
- 2002
- Market cap
- ₹379.2B
- Website
- https://www.ajantapharma.com
Loading AJANTPHARM…
Loading profile data…Frequently asked questions about AJANTPHARM
What does Ajanta Pharma Limited (AJANTPHARM.NS) do?
Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets finished dosages. The company markets and serves various therapeutic segments, such as anti-biotic, anti-malarial, anti-diabetic, cardiology, gynecology, pediatric, respiratory and general health products, de...
Where does AJANTPHARM.NS trade?
Ajanta Pharma Limited (AJANTPHARM.NS) trades on the National Stock Exchange of India.
What sector is AJANTPHARM.NS in?
Ajanta Pharma Limited (AJANTPHARM.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Ajanta Pharma Limited?
Yogesh Mannalal Agrawal is the chief executive officer of Ajanta Pharma Limited (AJANTPHARM.NS).
Where is Ajanta Pharma Limited headquartered?
Ajanta Pharma Limited is headquartered in India.
Does AJANTPHARM.NS pay a dividend?
Yes — Ajanta Pharma Limited (AJANTPHARM.NS) paid a trailing twelve-month dividend of INR 56.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did AJANTPHARM.NS go public?
Ajanta Pharma Limited (AJANTPHARM.NS) completed its initial public offering in 2002.